Source: http://www.google.com/patents/US5534018?dq=6,460,050
Timestamp: 2017-03-26 09:55:46
Document Index: 487432319

Matched Legal Cases: ['art 16', 'art 16', 'art 16', 'art 16', 'art 16', 'art 16']

Patent US5534018 - Automatic lead recognition for implantable medical device - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsA method and apparatus for determining the availability of unipolar and/or bipolar pacing/sensing paths in a body-implantable cardiac pacing system. In one embodiment, a pacemaker system includes impedance monitoring circuitry for periodically measuring impedance between pairs of electrodes that are...http://www.google.com/patents/US5534018?utm_source=gb-gplus-sharePatent US5534018 - Automatic lead recognition for implantable medical deviceAdvanced Patent SearchTry the new Google Patents, with machine-classified Google Scholar results, and Japanese and South Korean patents.Publication numberUS5534018 APublication typeGrantApplication numberUS 08/346,661Publication dateJul 9, 1996Filing dateNov 30, 1994Priority dateNov 30, 1994Fee statusPaidAlso published asWO1996016694A1Publication number08346661, 346661, US 5534018 A, US 5534018A, US-A-5534018, US5534018 A, US5534018AInventorsJohn D. Wahlstrand, Daniel J. Baxter, R. Michael Ecker, Daniel R. Greeninger, Charles G. YerichOriginal AssigneeMedtronic, Inc.Export CitationBiBTeX, EndNote, RefManPatent Citations (19), Referenced by (368), Classifications (9), Legal Events (4) External Links: USPTO, USPTO Assignment, EspacenetAutomatic lead recognition for implantable medical device
US 5534018 AAbstract
A method and apparatus for determining the availability of unipolar and/or bipolar pacing/sensing paths in a body-implantable cardiac pacing system. In one embodiment, a pacemaker system includes impedance monitoring circuitry for periodically measuring impedance between pairs of electrodes that are potentially available for pacing and/or sensing. This impedance monitoring circuitry includes circuitry for delivering excitation pulses between pairs of potentially available electrodes (including the pacemaker canister in the case of unipolar pacing or sensing), and for monitoring the current and voltage between those pairs of electrodes during delivery of an excitation pulse. Availability of a pair of electrodes for pacing and/or sensing is indicated if the impedance between a pair of electrodes is found to lie within a predetermined range. Detection of availability of a particular pair of electrodes is used initially as an indication that the pacing system has been implanted, and is also used to distinguish between unipolar and bipolar leads in the pacing system.
1. A body-implantable cardiac pacemaker system, comprising:an electronic circuit, wherein said electronic circuit comprises:an excitation circuit coupled to at least one conductor, for applying a sub-threshold symmetrical and bi-phasic voltage pulse along a current path; an impedance measurement circuit, coupled to said at least one conductor and to a second electrode, adapted to measure impedance along said current path during application of said sub-threshold voltage pulse; a comparison circuit, coupled to said impedance measurement circuit and adapted to determine whether said measured impedance lies within a predetermined impedance range, indicating availability of said current path for cardiac pacing; a hermetic enclosure for housing said electronic circuit; a flexible, elongate pacing/sensing lead having at least one conductor therein extending between proximal and distal ends of said lead, said at least one conductor being coupled at said proximal end to said electronic circuit in said hermetic enclosure and coupled near said distal end to a first conductive electrode adapted to be disposed in electrical contact with patient's cardiac tissue; a second electrode, electrically coupled to said electronic circuit in said hermetic enclosure, such that said current path is established extending from said electronic circuit, along said at least one lead to said electrode, through a portion of said patient's body tissue to said second electrode and back to said electronic circuit; Wherein said impedance measurement circuit further comprises:a sampling circuit for obtaining a sample of voltage between said first and second electrodes during said application of said excitation pulse and for obtaining a sample of current between said first and second electrodes during said application of said excitation pulse; an analog-to-digital converter for deriving a digital voltage value corresponding to a logarithm of said sampled voltage and a digital current value corresponding to the logarithm of said sampled current; and an impedance computation circuit for deriving from said digital voltage and current values a digital impedance value corresponding to the logarithm of the impedance between said first and second electrodes during application of said excitation pulse, wherein said voltage pulse is bi-phasic and on the order of 0.26 volts, peak to peak. 2. A body implantable cardiac pacemaker system for implantation into a patient's body:a hermetic enclosure for housing electronic circuitry; a flexible, elongate pacing/sensing lead having at least one conductor therein extending between proximal and distal ends of said lead, said at least one conductor being coupled at said proximal end to said electronic circuitry in said hermetic enclosure and coupled near to said distal end to a first conductive electrode adapted to be disposed in electrical contact with cardiac tissue in said patient's body; a second electrode, electrically coupled to said electronic circuitry in said hermetic enclosure, such that a current path is established extending from said electronic circuitry, along said at least one lead to said electrode, through a portion of said patient's body tissue to said second electrode and back to said electronic circuitry; said electronic circuitry comprising:an excitation circuit coupled to said at least one conductor, for applying a sub-threshold symmetrical and bi-phasic voltage pulse along said current path; an impedance measurement circuit, coupled to said at least one conductor and to said second electrode, adapted to measure impedance along said current path during application of said sub-threshold voltage pulse; a comparison circuit, coupled to said impedance measurement circuit and adapted to determine whether said measured impedance lies within a predetermined impedance range, indicating availability of said current path for cardiac pacing;wherein said voltage pulse is biphasic and on the order of 0.26 volts, peak to peak. Description
This invention relates generally to the field of automatic, body-implantable medical device systems, and more particularly to implantable device systems including one or more electrically conductive leads.
A wide assortment of automatic, body-implantable medical devices are presently known and commercially available. The class of such devices includes cardiac pacemakers, cardiac defibrillators and cardioverters, neural stimulators and many others.
In general, cardiac pacemakers are electrical devices used to supplant some or all of an abnormal heart's natural pacing function. Pacemakers typically operate to deliver appropriately timed electrical stimulation signals, sometimes called pacing pulses, designed to cause the myocardium to contract or "beat. "
Known and commercially available pacemakers are typically characterized according the chambers of the heart to which they are capable of delivering stimuli, and their responses, if any, to sensed intrinsic electrical cardiac activity. Some pacemakers, especially early ones, deliver pacing stimuli at fixed, regular intervals without regard to naturally occurring cardiac activity. More commonly at present, however, pacemakers sense electrical cardiac activity in one or both chambers of the heart, and inhibit or trigger delivery of pacing stimuli to the heart based upon the occurrence and recognition of such sensed intrinsic electrical events.
The Inter-Society Commission for Heart Diseases has established a standard three-letter descriptive code to characterize pacemakers. The first letter of the ICHD code indicates which chambers of the heart the pacemaker is capable of pacing (atrial (A), ventricular (V), or atrial and ventricular (D)). The second letter indicates which chambers of the heart the pacemaker is capable of sensing (A, V, or D), and the third letter indicates the response of the pacemaker to a sensed intrinsic event (triggered (T), inhibited (I), or dual (D)).
A VVI pacemaker, for example, senses electrical cardiac activity only in the ventricle of a patients heart, and delivers pacing stimuli only in the absence of sensed electrical signals indicative of natural ventricular contractions (an "inhibited" response). A DDD pacemaker, on the other hand, senses electrical activity in both the atrium and ventricle of the heart (an "inhibited" response), and delivers atrial pacing stimuli only in the absence of sensed signals indicative of natural atrial contractions, and ventricular stimuli only in the absence of sensed signals indicative of natural ventricular contractions (an "inhibited" response). The delivery of each stimulus by a DDD pacemaker is synchronized with prior sensed or paced events (a "triggered" response, and since the responses are also "inhibited" as noted above, the third letter in the ICHD code is "D").
Many state-of-the-art pacemakers are capable of performing either unipolar or bipolar sensing and of pacing in either chamber of the heart. Unipolar pacing requires an elongate lead having only one insulated conductor therein and only one generally distal electrode disposed thereon. As will be appreciated by those of ordinary skill in the art, in most unipolar configurations, the protective canister of the implanted device is conductive and functions as an electrode in pacing or sensing. In particular, for unipolar pacing the current path for stimulating pulses extends from the pacemaker's pulse generator, along the lead to the exposed distal electrode, through the cardiac tissue, and back to the pacemaker via the conductive canister.
For bipolar pacing and/or sensing, on the other hand, a lead having two mutually isolated conductors and two electrodes disposed thereon is required. Typically, one electrode is disposed at the distal end of the lead and is referred to as the "tip" electrode, while the second electrode is spaced back somewhat from the distal end of the lead and is referred to as a "ring" electrode. The current path for bipolar pacing extends from the pulse generator in the pacemaker, along a first of the two lead conductors to the tip electrode, through the cardiac tissue to the ring electrode, and back to the pacemaker along the second of the two lead conductors.
Typically, a fully-featured DDD pacemaker, since it is capable of sensing and pacing in both chambers of the heart, can be programmed to operate in modes other than DDD, for example, VVD, VVI, AAI, etc . . . . In addition, many state-of-the-art pacemakers can be programmed to operate in either unipolar or bipolar pacing and sensing modes. This gives the implanting physician considerable flexibility in configuring a pacing system to suit the particular needs of a given patient. In addition, since most of today's pacemakers are non-invasively programmable post-implant, the physician or clinician can re-program the already implanted device to operate in different modes and with different pacing and sensing polarities in response to changes in the patient's needs and condition.
Many pacemakers can accept and will operate with either unipolar or bipolar leads. Thus, it is important for the physician to be aware of which type of leads are used in a given instance, since it would be inappropriate to program the device into a bipolar pacing and/or sensing mode when only unipolar leads have been implanted. Similarly, if one of the two conductors or electrodes on an implanted bipolar lead were to fail for some reason (e.g., breakage of a conductor due to metal fatigue, poor connections between the lead and the pacemaker itself, tissue degradation at the electrode site, subclavian crushing of the lead, metal ion oxidation, short of lead conductors due to urethane/silicon breakdown, etc. . . ) it would be necessary to re-program the pacemaker into unipolar pacing and sensing modes in order for the pacemaker to function properly. The need for such re-programming due to lead failure or improper initial programming, however, would only become apparent upon careful examination of the patient in a clinical setting, which may not occur frequently enough to ensure proper operation of the pacemaker over a long term of implant.
In view of the foregoing, it is believed by the inventors that it would be advantageous to endow an implantable device such as a pacemaker with the ability to automatically and chronically distinguish between unipolar and bipolar leads coupled to it, and verify on an ongoing basis post-implant, the continued functionality of the leads.
Thus, the present invention is directed to a method and apparatus to be incorporated into an implantable device system for periodically performing a test to determine what type of pacing and sensing paths (i.e., unipolar or bipolar) are presently available to the device.
In one embodiment of the invention, an implantable pacemaker capable of both unipolar and bipolar pacing and sensing in one or both chambers of the heart uses sub-threshold impedance measurements on all potentially available pace/sense paths (atrial unipolar and bipolar, ventricular unipolar and bipolar) to perform various lead recognition functions, including, in the preferred embodiment, automatic implant detection, automatic implant polarity configuration, automatic bipolar lead monitoring, and polarity programming confirmation.
In accordance with one aspect of the present invention, automatic implant detection can be performed such that upon attachment of leads to the pacemaker and implantation in a patient, the system automatically detects characteristics of impedance on the pace/sense paths and determines that implantation has occurred. Then, the pacemaker can be automatically initialized to begin performing post-implant functions, for example, diagnostic functions, rate response function initialization, and the like, without physician intervention.
In accordance with another aspect of the present invention, automatic polarity configuration is available allowing the pacemaker to self-adapt to desired polarity modes once the device ascertains what modes are available based upon the types of leads used in a particular application.
In accordance with yet another aspect of the invention, bipolar lead monitoring is carried out on a chronic, ongoing basis, such that lead failures, even intermittent ones or ones that occur long after implant, can be detected and responded to, thereby enhancing the efficacy and reliability of the system. This monitoring can be configured to be asynchronous, or synchronized to sensed and/or paced events.
In accordance with still another aspect of the invention, polarity programming confirmation is provided automatically upon initiation of a non-invasive programming session, such that improper programming of the device is prevented.
The various lead recognition functions achievable with the present invention each involve the delivery of sub-threshold voltage pulses on each of the potentially available pace/sense paths of the system, in order to make measurements of the impedance observed along each of those paths. (By sub-threshold, it is meant that the energy level of the pulses delivered for the purposes of measuring pace/sense path impedance is lower than the patients stimulation threshold energy levels that could evoke a cardiac response.) The impedance measurements are then assessed in relation to predetermined control values to determine whether each potential pace/sense path is actually available.
The foregoing and other aspects of the present invention will perhaps be best understood with reference to a detailed description of a particular embodiment of the invention, when read in conjunction with the accompanying drawings, wherein:
FIG. 1 is an illustration of a pacemaker in accordance with one aspect of the present invention having been implanted in a conventional manner into a patient;
FIG. 2 is an block diagram of the pacemaker from FIG. 1;
FIG. 3 is a block diagram of lead recognition circuitry incorporated into the pacemaker from FIG. 1; and
FIG. 4 is an illustration of the waveform of subthreshold pulses delivered by the lead recognition circuitry from FIG. 3 for the purpose of carrying out impedance measurement.
Although the present invention will be described herein with reference to a specific embodiment of the invention, namely, a dual-chamber, unipolar- and bipolarcapable pacemaker, it is contemplated that the present invention may be advantageously practiced in connection with other types of body-implantable medical device systems having multiple conductive paths potentially available for the purposes of performing sensing of electrical signals or delivery of electrical signals. It is believed that adaptation of the present invention as described herein to such other applications would be readily accomplished by those of ordinary skill in the art having the benefit of this disclosure.
Referring to FIG. 1, there is shown an illustration of generally where a pacemaker 10 in accordance with one embodiment of the invention may be implanted in a patient 12. In accordance with conventional practice in the art, pacemaker 10 is housed within a hermetically sealed, biologically inert outer canister, which may itself be conductive and thus serve as an indifferent electrode in the pacemaker's pacing/sensing circuit. One or more pacemaker leads, collectively identified with reference numeral 14 in FIG. 1 are electrically coupled to pacemaker 10 in a conventional manner, extending into the patient's heart 16 via a vein 18. Disposed generally near the distal end of lead 14 are one or more exposed conductive electrodes for receiving electrical cardiac signals and/or for delivering electrical pacing stimuli to heart 16. As will be appreciated by those of ordinary skill in the art, lead 14 may be implanted with its distal end situated in either the atrium or ventricle of heart 16.
Turning now to FIG. 2, there is shown a block diagram of the electronic circuitry which makes up pacemaker 10 in accordance with the presently disclosed embodiment of the invention. As can be seen from FIG. 2, pacemaker 10 comprises a primary pacing/control circuit 20 and, in accordance with an important aspect of the present invention, a lead recognition circuit 22. (It is contemplated by the inventors that the block designated lead recognition circuit 22 in FIG. 2 may in one implementation of the invention be associated with circuitry for performing other pacemaker-related functions. For example, in one embodiment of the invention, circuit 22 additionally comprises circuitry for supporting activity and/or minute ventilation sensing in a rate-responsive cardiac pacemaker. Such an arrangement is described in co-pending U.S. patent application by Yerich et al. for a "Method and Apparatus for Rate Responsive Cardiac Pacing", filed as of the date of the present application and which is hereby incorporated by reference herein in its entirety. For the purposes of the present invention, however, only the circuitry in block 22 associated with the pacemaker's automatic lead recognition function will be described.
Much of the circuitry associated with pacing control circuit 20 is of conventional design, in accordance, for example, with what is disclosed in U.S. Pat. No. 5,052,388 to Sivula et al, entitled "Method and Apparatus for Implementing Activity Sensing in a Pulse Generator." The Sivula et al. '388 patent is hereby incorporated by reference herein in its entirety. To the extent that certain components of pacemaker 10 are purely conventional in their design and operation, such components will not be described herein in detail, as it is believed that design and implementation of such components would be a matter of routine to those of ordinary skill in the art. For example, pacing/control circuit 20 in FIG. 2 includes sense amplifier circuitry 24, pacing output circuitry 26, a crystal clock 28, a random-access memory and read-only memory (RAM/ROM) unit 30, a central processing unit (CPU) 32, and a telemetry circuit 34, all of which are well-known in the art.
Pacemaker 10 preferably includes an internal telemetry circuit 34 so that it is capable of being programmed by means of external programmer/control unit 17 (not shown in FIG. 1 ). Programmers and telemetry systems suitable for use in the practice of the present invention have been well known for many years.
Known programmers typically communicate with an implanted device via a bidirectional radio-frequency telemetry link, so that the programmer can transmit control commands and operational parameter values to be received by the implanted device, and so that the implanted device can communicate diagnostic and operational data to the programmer. Programmers believed to be suitable for the purposes of practicing the present invention include the Model 9760 and Model 9790 Programmers, commercially-available from Medtronic, Inc., Minneapolis, Minn.
Various telemetry systems for providing the necessary communications channels between an external programming unit and an implanted device have been developed and are well-known in the art. Telemetry systems believed to be suitable for the purposes of practicing the present invention are disclosed, for example, in the following U.S. Patents: U.S. Pat. No. 5,127,404 to Wyborny et al. entitled "Telemetry Format for Implanted Medical Device"; U.S. Pat. No. 4,374,382 to Markowitz entitled "Marker Channel Telemetry System for a Medical Device"; and U.S. Pat. No. 4,556,063 to Thompson et al. entitled "Telemetry System for a Medical Device". The Wyborny et al. '404, Markowitz '382, and Thompson et al. '063 patents are commonly assigned to the assignee of the present invention, and are each hereby incorporated by reference herein in their respective entireties.
Typically, telemetry systems such as those described in the above-referenced patents are employed in conjunction with an external programming/processing unit. One programmer for non-invasively programming a cardiac pacemaker is described in the above-referenced Hartlaub et al. '884 patent.
Most commonly, telemetry systems for implantable medical devices employ a radio-frequency (RF) transmitter and receiver in the device, and a corresponding RF transmitter and receiver in the external programming unit. Within the implantable device, the transmitter and receiver utilize a wire coil as an antenna for receiving downlink telemetry signals and for radiating RF signals for uplink telemetry. The system is modelled as an air-core coupled transformer. An example of such a telemetry system is shown in the above-referenced Thompson et al. '063 patent.
In order to communicate digital data using RF telemetry, a digital encoding scheme such as is described in the above-reference Wyborny et al. '404 patent can be used. In particular, for downlink telemetry a pulse interval modulation scheme may be employed, wherein the external programmer transmits a series of short RF "bursts" or pulses in which the interval between successive pulses (e.g., the interval from the trailing edge of one pulse to the trailing edge of the next) is modulated according to the data to be transmitted. For example, a shorter interval may encodes a digital "0" bit while a longer interval encodes a digital "1" bit.
For uplink telemetry, a pulse position modulation scheme may be employed to encode uplink telemetry data. For pulse position modulation, a plurality of time slots are defined in a data frame, and the presence or absence of pulses transmitted during each time slot encodes the data. For example, a sixteen position data frame may be defined, wherein a pulse in one of the time slots represents a unique four bit portion of data.
As depicted in FIG. 1, programming units such as the above-referenced Medtronic Model 9760 and 9790 programmers typically interface with the implanted device through the use of a programming head or programming paddle, a handheld unit adapted to be placed on the patient's body over the implant site of the patient's implanted device. A magnet in the programming head effects reed switch closure in the implanted device to initiate a telemetry session. Thereafter, uplink and downlink communication takes place between the implanted device's transmitter and receiver and a receiver and transmitter disposed within the programming head.
With continued reference to FIG. 2, pacemaker 10 is coupled to leads 14 which, when implanted, extend transvenously between the implant site of pacemaker 10 and the patient's heart 16, as previously noted with reference to FIG. 1. For the sake of clarity, the connections between leads 14 and the various components of pacemaker 10 are not shown in FIG. 2, although it will be clear to those of ordinary skill in the art that, for example, leads 14 will necessarily be coupled, either directly or indirectly, to sense amplifier circuitry 24 and pacing output circuit 26, in accordance with common practice, such that cardiac electrical signals may be conveyed to sensing circuitry 24, and pacing pulses may be delivered to cardiac tissue, via leads 14.
In the presently disclosed embodiment, two bipolar leads are employed--an atrial lead 14A having atrial tip and ring electrodes (ATIP and ARING in FIG. 2), and a ventricular lead 14V having ventricular tip and ring electrodes (VTIP and VRING in FIG. 2). Those of ordinary skill in the art will appreciate that a separate, electrically insulated conductor extending along the length of leads 14A and 14V is associated with each of the electrodes ATIP, ARING, VTIP, and VRING. That is, electrical signals applied, for example, to the VRING electrode are conducted along lead 14V on a first conductor (wire), whereas signals applied to the VTIP electrode are conducted along a second, separate, conductor in lead 14V. In addition, as noted above, the conductive hermetic canister 11 of pacemaker 10 serves as an indifferent electrode (CASE in FIG. 2).
As previously noted, pace/control circuit 20 includes central processing unit 32 which may be an off-the-shelf programmable microprocessor or microcontroller, but in the presently preferred embodiment of the invention is a custom integrated circuit. Although specific connections between CPU 32 and other components of pace/control circuit 20 are not shown in FIG. 2, it will be apparent to those of ordinary skill in the art that CPU 32 functions to control the timed operation of pacing output circuit 26 and sense amplifier circuit 24 under control of programming stored in RAM/ROM unit 30. It is believed that those of ordinary skill in the art will be familiar with such an operative arrangement.
With continued reference to FIG. 2, crystal oscillator circuit 28, in the presently preferred embodiment a 32,768-Hz crystal controlled oscillator, provides main timing clock signals to pace/control circuit 20 and to lead recognition circuit 22.
It is to be understood that the various components of pacemaker 10 depicted in FIG. 2 are powered by means of a battery (not shown) which is contained within the hermetic enclosure 11 of pacemaker 10, in accordance with common practice in the art. For the sake of clarity in the Figures, the battery and the connections between it and the other components of pacemaker 10 are not shown.
Pacing output circuit 26, which functions to generate pacing stimuli under control of signals issued by CPU 32, may be, for example, of the type disclosed in U.S. Pat. No. 4,476,868 to Thompson, entitled "Body Stimulator Output Circuit," which patent is hereby incorporated by reference herein in its entirety. Again, however, it is believed that those of ordinary skill in the art could select from among many various types of prior art pacing output circuits which would be suitable for the purposes of practicing the present invention.
As shown in FIG. 2, pace/control circuit 20 is coupled to lead recognition circuit 22 by means of multiple signal lines, designated collectively as 38 in FIG. 2. An I/O interface 40 in pace/control circuit 20 and a corresponding I/O interface 42 in lead recognition circuit 22 function to coordinate the transmission of signals between the two units 20 and 22.
With continued reference to FIG. 2, lead recognition circuit 22 includes a lead interface circuit 44, which essentially functions as a multiplexer to selectively couple the lead conductors associated with the ATIP, ARING, VTIP, and VRING electrodes of leads 14A and 14V to the remaining components of lead recognition circuitry 22. In the preferred embodiment, the selection of particular conductors can accomplished by interface circuit 44 under control of control signals originating from pace/control circuit 20 and communicated to lead interface circuit 44 via lines 38.
Coupled to lead interface circuit 44 in lead recognition circuit 22 is an excitation and sample circuit 50 which, as will be hereinafter described in greater detail, functions to generate biphasic excitation pulses which are conveyed along leads 14A and/or 14V for the purposes of measuring impedance between various combinations of electrodes ATIP, ARING, VTIP, and VRING, as determined by the multiplexing function of lead interface circuit 44. In addition, excitation and sample circuit 50 performs a sampling function on electrical signals present on the conductors of leads 14A and 14V.
The sample values obtained by excitation and sample circuit 50 are provided to a logarithmic analog-to-digital converter ("logadc") circuit 52. As its name suggests, logadc circuit 52 performs a logarithmic analog-to-digital conversion function on the sample values obtained by sample and excitation circuit 50, resulting in the derivation of values corresponding to the current and voltage on the conductors of leads 14A and 14V. These values, in turn, are used to derive an impedance value reflecting the impedance associated with a given pacing path defined by the conductors of leads 14A and 14V. This impedance value is determined in a digital interface circuit 54 which also functions to coordinate the transfer of digital information between lead recognition circuit 22 and pace/control circuit 20 on lines 38.
Finally, an lead recognition voltage regulator ("lrreg") circuit 56 is provided to define a reference voltage used by excitation and sample circuit 50.
Another block diagram of lead recognition circuit 22 in accordance with the presently disclosed embodiment of the invention is provided in FIG. 3. The block diagram of FIG. 3 is somewhat more detailed than that of FIG. 2, in that it shows more of the individual connections between components of lead recognition circuit 22.
As shown in FIG. 3, leads 14A and 14V extend between the patient's heart 16 and lead interface circuit 44. Since each lead 14A and 14V includes two separate internal conductors, leads 14A and 14V convey four separate electrical signals to lead interface circuit 44. Specifically, lead 14A conducts an atrial tip (AT) signal from its ATIP electrode and an atrial ring (AR) signal from its ARING electrode. Similarly, lead 14V conducts a ventricular tip (VT) signal and a ventricular ring (VR) signal from its VTIP and VRING electrodes, respectively. In addition, a signal C from the conductive case 11 of pacemaker 10, acting as an additional (fifth) electrode, is provided to interface circuit 44.
As will be familiar to those of ordinary skill in the art, the provision of two bipolar leads 14A and 14V, along with the use of the pacemaker's conductive canister as an additional electrode, allows a number of different pacing and sensing paths to be established in each chamber of the heart. In the atrial chamber, an atrial unipolar pacing/sensing path can be established wherein pacing pulses are delivered between one of the atrial tip electrode ATIP and the conductive canister (CAN) electrode. Alternatively, an atrial bipolar pacing/sensing path can be established, wherein pacing pulses are delivered between the ATIP and ARING electrodes of atrial lead 14A. Similarly, in the ventricular chamber, ventricular unipolar (VTIP-to-CASE) or bipolar (VTIP-to-VRING) pacing/sensing paths can be established.
Typically, and in the preferred embodiment, the pacing and sensing paths for each chamber of heart 16 are programmably selectable post-implant. Thus, although pacemaker 10 may be capable of operating in either unipolar or bipolar pacing modes in each chamber, the implanting physician may determine that unipolar pacing is preferred in view of the patient's particular condition, and can program pacemaker 10 accordingly. It is also common that a pacemaker, although operable in either unipolar or bipolar pacing/sensing modes, may be implanted with unipolar leads, thus making it impermissible for the pacemaker to be programmed into a bipolar mode.
As noted in the Summary of the Invention above, the present invention relates to a method and apparatus for automatically detecting when the pacemaker has been implanted in a patient, with either unipolar or bipolar leads, and further for automatically detecting what types of leads have been coupled to the pacemaker at implant. This is accomplished through delivery of sub-threshold biphasic voltage pulses on the possible pacing/sensing paths (atrial unipolar and bipolar, ventricular unipolar and bipolar), such that the impedances observed along those paths can be evaluated.
To this end, and with continued reference to FIG. 3, excitation and sample circuit 50 includes circuitry for generating the small sub-threshold biphasic voltage pulses, which, through lead interface circuit 44 are periodically and sequentially issued along each of the four possible pacing paths. An illustration of the biphasic pulse waveform generated by excitation and sample circuit 50 is shown in FIG. 4. As shown in FIG. 4, the biphasic pulses have 0.26-V peak-to-peak amplitudes, and last for 30-μSec (15-μSec each phase). The 0.26-V biphasic pulses are applied across the series combination of (1) a reference resistor, designated with reference numeral 53 in FIG. 3, and (2) the resistance through the lead conductors and heart. It is believed that the biphasic nature of the sub-threshold pulses offers the advantages over a monophasic pulse that the peak amplitude of each pulse is minimized given the overall energy content of the pulse, electrode polarization is canceled, and DC current is balanced to avoid longterm lead metal-ion oxidation. It is believed that the implementation of circuitry for generating pulses such as depicted in FIG. 4 would be a matter of routine engineering to those of ordinary skill in the art; therefore, the details of such circuitry will not be described further herein.
Returning to FIG. 3, lead interface circuit 44 functions in a multiplexer-like capacity during a lead recognition measurement circuit to direct a biphasic pulse from excitation and sample circuit 50 to each of the four pacing paths. Thus, during each measurement cycle, up to four excitation pulses are delivered. When a pulse is delivered along a given path, the resulting current and voltage are measured.
In the presently preferred embodiment of the invention, lead recognition measurement cycles can be triggered either synchronously or asynchronously with respect to the patient's cardiac function. Asynchronous measurement cycles occur once per second, while synchronous measurement cycles are initiated a predetermined time period following a paced or non-refractory sensed event in the chamber being measured. In the presently preferred embodiment, synchronous mode measurements are synchronized off of cardiac events (sensed and paced), so that the frequency and timing within the cardiac cycle of the measurements is related to the pacing and intrinsic rate. The predetermined delay period between detection of a sensed or paced cardiac event in a given cardiac chamber and delivery of sub-threshold pulse to that chamber may be among the programmably selectable parameters of pacemaker 10, in accordance with well-known practice in the art.
As noted above, when a sub-threshold biphasic pulse is delivered on a given path, the resultant voltage and current on that path are monitored. To this end, excitation and sample circuit 50 includes circuitry for obtaining samples of the voltage and current on the path being measured. In the presently preferred embodiment of the invention, the sampling rate is programmable, although the rate presently preferred is 1-Hz (i.e., one sample each second on each output/sensing path). For each measurement, the peak-to-peak voltage across the heart leads and the peak-to-peak voltage across reference resistor 53 are simultaneously sampled. Reference resistor 53 is configured in series with the heart so that the reference resistor's current is equal to that delivered to the heart. The voltage across reference resistor 53 is directly proportional to the current through the heart. After the sub-threshold pulse is delivered and the two resulting voltages are sampled, two multiple-cycle analog-to-digital conversions ensue. The conversions occur within logadc circuit 52 using the two sampled voltages available on the VIN and IIN lines. The VSEL control signal input to logadc circuit 52 selects between VIN and IIN. The result of each conversion appears at the LOGCOMP output as a serial bitstream.
For each sampling cycle of a given measurement cycle, digital interface circuit 54 produces two 7-bit digital values, VCODE and ICODE, from the serial bitstream provided by logadc circuit 52. The VCODE and ICODE values reflect the logarithm of the voltage sample VIN and the logarithm of the current sample IIN, respectively. These logarithmic values VCODE and ICODE are provided to digital interface circuit 54, where they are then subtracted, VCODE minus ICODE, to produce an impedance value (ZCODE).
ZCODE is a logarithmic value, and is related to impedance observed on the path being measured as follows:
LEAD IMPEDANCE (in ohms)=500×(1+0.0741)ZCODEI The ICODE and VCODE values have an absolute range from zero to 127 (seven bits). More realistic values in actual use are in the range from zero to 45, corresponding to voltages of 10.4- to 259.4-mV and currents of 20.8- to 518.8-μA on the path being measured. The ZCODE value has an absolute range of-127 to +127 (eight bits), while the typical range is -32 to +45, corresponding to path impedances in the range from 50- to 12,500-Ω.
The ICODE and VCODE values derived during each sampling cycle of each measurement cycle are supplied via I/O lines 38 to pace/control circuit 20, where CPU 32 computes the corresponding ZCODE value. To support the lead recognition function in pacemaker 10, pace/control circuit 20 maintains a number of values in memory unit 30. Among these values are four path monitor values (a separate path monitor value is maintained for each of the four possible paths--atrial unipolar and bipolar, ventricular unipolar and bipolar). A path monitor status value is also maintained for each path, where the path monitor status value is an indicator of recent individual lead impedance measurements taken on the path to which it corresponds.
The resultant ZCODE value from each single path measurement is compared against two values, MINZ and MAXZ that correspond to normal lead impedances. If the measurement is greater than or equal to MINZ and less than or equal to MAXZ, the individual measurement is in-range; otherwise it is out-of-range.
Individual path monitor values in the path monitor registers are updated after both measurements for a given chamber have occurred during a measurement cycle. If both the bipolar path measurement and the unipolar path measurement for a given chamber are out-of-range, the updates for the two path monitors for that chamber are skipped. Otherwise, each path monitor uses the single measurement range result to update the individual path monitor status.
In the presently preferred embodiment, each path monitor register is a 32-bit shift register; also, associated with each path monitor register is an out-of-range counter. Updating of the path monitors occurs as follows: For each path monitor update, a bit is shifted into the path monitor shift register. The bit will be 0 if the measurement is in range, and 1 if the measurement is out-of-range. If the bit shifted in is a 1, the out-of-range counter is incremented. If the bit shifted out is a 1, the out-of-range counter is decremented.
The path monitor shift register and out-of-range counter for each path form an M-of-N monitor, where M is the number of measurements out of range over the last N measurements (N being the size in bits of the path monitor shift register).
For each measurement cycle, the status of the four path monitors is updated and evaluated. If the value of a path's out-of-range counter is equal to or greater than a predetermined (programmed) M value, the path monitor status register (which need be only 1-bit) is set to out-of-range; otherwise the path monitor status register is set to in-range. (In the presently preferred embodiment, initializing the path monitors involves setting all shift registers and out-of-range counters to contain all zeros, and setting all path monitor status bits to in-range.)
Path monitors are preferably frozen during any programming session, as evidenced by any valid programmer downlink. A measurement cycle in progress upon initiation of a programming session will be terminated and path monitor updates will not be made.
In the presently preferred embodiment of the invention, telemetry circuit 34 issues a signal on a line 55 (see FIG. 2) between telemetry circuit 34 and digital interface circuit 54 if RF signals are detected during a measurement cycle. The signal on line 55 tells interface circuit 54 to disregard the measurement values if RF is detected during the measurement cycle. This feature provides a desired level of immunity to RF downlink, since downlink RF bursts can induce energy on the lead system and confound the measurement.
The lead recognition feature of pacemaker 10 as thus far described may be advantageously utilized for several distinct functions: Implant Detection, Implant Polarity Configuration, Lead Monitoring, and Polarity Programming Confirmation. Implant Detection involves automatically recognizing when implant has occurred, and is beneficial for the purpose of initiating other processes in pacemaker 10, such as rate-response initialization and diagnostic data collection. Implant Polarity Configuration involves automatically configuring pacing and sensing polarities for each chamber based on the lead(s) implanted. Lead Monitoring entails monitoring each lead impedance value in each chamber, and comparing the results against programmable range and sensitivity criteria to determine lead status. If the criteria are met, the time and date are recorded. The Lead Monitor function may also involve automatically switching the pacing and sensing polarities from bipolar to unipolar (or vice versa) and/or providing a warning to a physician or clinician attempting to program the pacemaker to a bipolar pacing or sensing path when criteria for a viable bipolar path are not met.
Each of the above-described lead recognition functions can preferably be individually enabled and disabled. Implant Detection and Lead Monitoring are never active at the same time. Two time periods can be thought to exist: implant time, where Implant Detection is in progress and Implant Polarity Configuration can be either enabled or disabled, and chronic time, where Lead Monitoring and its various options may be either enabled or disabled by means of the programming system.
The Implant Detection function has two states: On and Off/Complete. During Implant Detection, lead recognition measurements are preferably made asynchronously and the path monitors will be updated to reflect path status. The Implant Detection function also preferably uses a count-down timer and the path monitor status registers to determine when implant has occurred. The count-down timer decrements once per second while the path monitors meet certain criteria, set forth below. If the criteria are not met, the timer resets itself to is maximum value.
The status of the path monitors are checked at the completion of each measurement cycle. The current path monitor status combination is compared to the path monitor status combination from the previous measurement cycle. If the current path monitor status combination is not one of the three listed below or is not the same as the previous path monitor status combination, the time is reset to its maximum value.
In the presently preferred dual-chamber embodiment of the invention, the three valid path monitor status combinations are as follows:
______________________________________1.      Atrial Unipolar Path:                      In-Range   Ventricular Unipolar Path:                      In-Range   Atrial Bipolar Path:                      In-Range   Ventricular Bipolar Path:                      Out-Of-Range2.      Atrial Unipolar Path:                      In-Range   Ventricular Unipolar Path:                      In-Range   Atrial Bipolar Path:                      Out-Of-Range   Ventricular Bipolar Path:                      In-Range3.      Atrial Unipolar Path:                      In-Range   Ventricular Unipolar Path:                      In-Range   Atrial Bipolar Path:                      In-Range   Ventricular Bipolar Path:                      In-Range______________________________________
(The foregoing valid path monitor status combinations are specific to a particular bipolar pacemaker system. It is believed that those of ordinary skill in the art would comprehend that different combinations might be considered valid depending upon the particular pacing system with which the present invention is practiced.)
If Implant Detection is in progress and a programming session is initiated, the count-down timer is preferably frozen.
When the Implant Detection count-down timer reaches zero, the Implant Detection function terminates. At this time, if Implant Polarity Configuration is enabled, the bipolar path monitor status for each chamber is evaluated. If the bipolar path monitor status is in-range, the permanent pacing and sensing polarities for that chamber are set to or remain bipolar. If the bipolar path monitor status is out-of-range, the permanent pacing and sensing polarities for that chamber are set to or remain unipolar. The new polarities are put into effect at the start of the next pacing cycle.
Termination of the Implant Detection function can also cause the initiation of other pacemaker processes, as previously noted, including automatic initialization of rate-response function (which may involve accumulating patient data over a period of time before activation of rate-response operation--see the above-referenced U.S. patent application by Yerich et al.
If the Lead Monitor function is enabled, termination of the Implant Detection function also preferably causes reinitialization of all path monitors to in-range, loading of all path monitor shift registers with zeroes, and setting of all path monitor out-of-range counters to zero. If the Lead Monitor function is not enabled, all path monitors are frozen.
The Implant Detection function can be forced to complete via a command transmitted downlink from the external programmer. Likewise, the programmer can restart Implant Detection.
The Implant Polarity Configuration feature automatically sets pacing and sensing polarities individually for each chamber. Implant Polarity Configuration can be operational only while Implant Detection is in progress, and can be individually programmed On or Off. Implant Polarity Configuration uses the individual measurement cycle results acquired while Implant Detection is in progress, and each chamber is evaluated individually.
For Implant Polarity Configuration, if the most recent chamber bipolar measurement is in-range, the permanent pacing and sensing polarities are set to or remain bipolar. If the most recent chamber bipolar path is out-of-range, the permanent pacing and sensing polarities are set to or remain unipolar. The new polarities are put into effect at the start of the next pacing cycle. The pacing and sensing polarity decision is made with each measurement cycle.
The Lead Monitor function can be programmed to either "On", "On plus atrial polarity switch", "On plus ventricular polarity switch", or "On plus ventricular and atrial polarity switch." When Lead Monitor is active, the monitor trip criteria for each chamber are evaluated separately at the end of each cycle following completion of path monitor status updates. If the atrial path monitor changes from in-range to out-of-range and the atrial pace and sense polarities are not both unipolar, the atrial trip criteria are met. Similarly, if the ventricular path monitor changes from in-range to out-of-range and the ventricular pace and sense polarities are not both unipolar, the ventricular trip criteria are met.
When a given chamber's trip criteria is met, as set forth above, the following actions are taken:
1. A "trip-bit" maintained in memory by the pace/control circuitry 20 is set and a timestamp is recorded.
2. If the chamber polarity switch bit is set (i.e., if Bipolar Lead Monitor is enabled to "On plus atrial and/or ventricular polarity switch," as described above), the permanent pace and sense polarity will be set to unipolar for that chamber, starting at the beginning of the next pacing cycle.
An additional function of pacemaker 10 in connection with its lead recognition capability is Polarity Programming Confirmation, which may be enabled or disabled independently from the Implant Detect and Lead Monitor functions. At the start of a programming session, a single asynchronous lead recognition measurement cycle is initiated. At the completion of the measurement cycle, the ICODE and VCODE from that cycle are stored in a reserved memory location maintained by pacing/control circuit 20. These measured values are not used by the path monitors. The programmer can then interrogate pacemaker 10 and use the stored ICODE and VCODE to verify that a chamber's bipolar path is in-range before allowing the programmer to request pacing or sensing bipolarity for a given chamber.
(In an alternative implementation of the Polarity Programming Confirmation function, the most recent measurement results can be used as the Polarity Programming Confirmation data, combined with Path Monitor status to determine bipolar availability.)
Still another embodiment of the invention contemplated by the inventors involves operation of the lead recognition functions synchronously with the device's pacing and/or sensing functions. In this embodiment, lead recognition excitation pulses are delivered after a predetermined delay interval following paced and/or sensed events. The predetermined delay may be swept through its available range (determined by hardware) to detect lead fractures or shorts which might not be discernable with a fixed delay interval. This may be desirable because the effects of such fractures or shorts may be more or less discernable depending upon the amount of flex to the lead, which in turn is dependent upon cardiac activity.
In one embodiment of the invention contemplated by the inventors, lead recognition markers can be incorporated into the marker channel uplink (see the above-referenced Markowitz '382 patent).
From the foregoing detailed description of a specific embodiment of the invention, it should be apparent that a method and apparatus for providing a body-implantable medical device with the capability of recognizing the presence or absence of conductive leads coupled thereto through impedance measurement has been disclosed, and further that applications of this capability to provide such automatic implant detection, automatic implant polarity configuration, automatic and chronic bipolar lead monitoring, and polarity programming confirmation have been disclosed.
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS3965418 *Mar 6, 1975Jun 22, 1976Wiltron CompanyTelephone system testing apparatus and techniques utilizing central measuring equipment with a plurality of remote test stationsUS4250884 *Nov 6, 1978Feb 17, 1981Medtronic, Inc.Apparatus for and method of programming the minimum energy threshold for pacing pulses to be applied to a patient's heartUS4290430 *Jun 5, 1980Sep 22, 1981Intermedics, Inc.Pacer analyzerUS4374382 *Jan 16, 1981Feb 15, 1983Medtronic, Inc.Marker channel telemetry system for a medical deviceUS4476868 *Sep 8, 1980Oct 16, 1984Medtronic, Inc.Body stimulator output circuitUS4556063 *Dec 7, 1984Dec 3, 1985Medtronic, Inc.Telemetry system for a medical deviceUS4790318 *Jun 16, 1986Dec 13, 1988Siemens AktiengesellschaftCardiac pacer for pacing a human heartUS4805621 *Jun 15, 1987Feb 21, 1989Siemens AktiengesellschaftApparatus for measuring impedance of body tissueUS4901725 *Jan 29, 1988Feb 20, 1990Telectronics N.V.Minute volume rate-responsive pacemakerUS4951682 *Apr 26, 1989Aug 28, 1990The Cleveland Clinic FoundationContinuous cardiac output by impedance measurements in the heartUS4964407 *Aug 29, 1988Oct 23, 1990Intermedics, Inc.Method and apparatus for assuring pacer programming is compatible with the leadUS5003975 *Oct 17, 1989Apr 2, 1991Siemens-Pacesetter, Inc.Automatic electrode configuration of an implantable pacemakerUS5052388 *Dec 22, 1989Oct 1, 1991Medtronic, Inc.Method and apparatus for implementing activity sensing in a pulse generatorUS5127404 *Sep 25, 1991Jul 7, 1992Medtronic, Inc.Telemetry format for implanted medical deviceUS5201808 *Feb 10, 1992Apr 13, 1993Telectronics Pacing Systems, Inc.Minute volume rate-responsive pacemaker employing impedance sensing on a unipolar leadUS5318593 *Nov 18, 1991Jun 7, 1994Medtronic, Inc.Multi-mode adaptable implantable pacemakerUS5413593 *Jan 31, 1994May 9, 1995Cardiac Pacemakers, Inc.Using sub-threshold unipolar pacing markers to improve the interpretation of surface EKG in pacemaker patientsEP0338363A2 *Apr 10, 1989Oct 25, 1989Pacesetter ABConfiguration programming of an implantable pacemakerEP0338364A2 *Apr 10, 1989Oct 25, 1989Pacesetter ABLead impedance scanning system for pacemakers* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS5713935 *Aug 23, 1996Feb 3, 1998Sulzer Intermedics Inc.Method and apparatus for monitored biphasic cardiac impedance sensingUS5755742 *Nov 5, 1996May 26, 1998Medtronic, Inc.Cardioversion/defibrillation lead impedance measurement systemUS5814088 *Mar 26, 1997Sep 29, 1998Sulzer Intermedics Inc.Cardiac stimulator with lead failure detector and warning systemUS5837900 *Jun 21, 1996Nov 17, 1998Medtronic IncSystem and method for detecting metal ion oxidation in pacing leadUS5871506 *Aug 19, 1996Feb 16, 1999Mower; Morton M.Augmentation of electrical conduction and contractility by biphasic cardiac pacingUS5876353 *Jan 31, 1997Mar 2, 1999Medtronic, Inc.Impedance monitor for discerning edema through evaluation of respiratory rateUS5897577 *Nov 7, 1997Apr 27, 1999Medtronic, Inc.Pacing lead impedance monitoring circuit and methodUS5910156 *Nov 7, 1997Jun 8, 1999Medtronic Inc.Non-physiologic sense detection for implantable medical devicesUS5944746 *Oct 30, 1998Aug 31, 1999Pacesetter, Inc.ICD with continuous regular testing of defibrillation lead statusUS5957861 *Jan 31, 1997Sep 28, 1999Medtronic, Inc.Impedance monitor for discerning edema through evaluation of respiratory rateUS6016448 *Oct 27, 1998Jan 18, 2000Medtronic, Inc.Multilevel ERI for implantable medical devicesUS6044294 *Dec 13, 1996Mar 28, 2000Pacesetter, Inc.Methods and apparatus for measuring impedance in the bodyUS6136019 *Jan 16, 1998Oct 24, 2000Mower Family Chf Treatment Irrevocable TrustAugmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood poolUS6141585 *May 8, 1998Oct 31, 2000Intermedics Inc.Implantable cardiac stimulator with electrode-tissue interface characterizationUS6141587 *May 27, 1998Oct 31, 2000Mower Family Chf Treatment Irrevocable TrustAugmentation of muscle contractility by biphasic stimulationUS6200265Apr 16, 1999Mar 13, 2001Medtronic, Inc.Peripheral memory patch and access method for use with an implantable medical deviceUS6269264 *Jun 3, 1999Jul 31, 2001Pacesetter, Inc.Method for measuring impedance in the bodyUS6282446Aug 24, 1999Aug 28, 2001Cardiac Pacemakers, Inc.Automatic shock lead gain adjusterUS6317633Jan 19, 2000Nov 13, 2001Medtronic, Inc.Implantable lead functional status monitor and methodUS6332096Feb 16, 2000Dec 18, 2001Mower Chf Treatment Irrevocable TrustAugmentation of electrical conduction and contractility by biphasic cardiac pacingUS6337995Nov 13, 2000Jan 8, 2002Mower Chf Treatment Irrevocable TrustAtrial sensing and multiple site stimulation as intervention for atrial fibrillationUS6341235Oct 18, 2000Jan 22, 2002Mower Chf Treatment Irrevocable TrustAugmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood poolUS6343232Oct 19, 2000Jan 29, 2002Mower Chf Treatment Irrevocable TrustAugmentation of muscle contractility by biphasic stimulationUS6402741Oct 8, 1999Jun 11, 2002Sherwood Services AgCurrent and status monitorUS6411845Sep 5, 2000Jun 25, 2002Mower Chf Treatment Irrevocable TrustSystem for multiple site biphasic stimulation to revert ventricular arrhythmiasUS6411847Sep 22, 2000Jun 25, 2002Morton M. MowerApparatus for applying cyclic pacing at an average rate just above the intrinsic heart rateUS6445952May 18, 2000Sep 3, 2002Medtronic, Inc.Apparatus and method for detecting micro-dislodgment of a pacing leadUS6473648Dec 6, 1999Oct 29, 2002Intermedics Inc.Implantable cardiac stimulator with electrode-tissue interface characterizationUS6505072 *Nov 16, 2000Jan 7, 2003Cardiac Pacemakers, Inc.Implantable electronic stimulator having isolation transformer input to telemetry circuitsUS6512949 *Jul 12, 1999Jan 28, 2003Medtronic, Inc.Implantable medical device for measuring time varying physiologic conditions especially edema and for responding theretoUS6564099Dec 6, 1999May 13, 2003Intermedics, Inc.Implantable cardiac stimulator with electrode-tissue interface characterizationUS6591136Jul 9, 2001Jul 8, 2003Cardiac Pacemakers, Inc.Automatic shock lead gain adjusterUS6675049Jul 17, 2001Jan 6, 2004Medtronic, Inc.Method and apparatus for automatic implantable medical lead recognition and configurationUS6681135Nov 22, 2000Jan 20, 2004Medtronic, Inc.System and method for employing temperature measurements to control the operation of an implantable medical deviceUS6721600Dec 31, 2001Apr 13, 2004Medtronic, Inc.Implantable lead functional status monitor and methodUS6778855Jul 9, 2001Aug 17, 2004Cardiac Pacemakers, Inc.Automatic shock lead gain adjusterUS6788972Feb 21, 2003Sep 7, 2004Intermedics Inc.Implantable cardiac stimulator with electrode-tissue interface characterizationUS6834205Jan 20, 2004Dec 21, 2004Cardiac Pacemakers, Inc.Automatic shock lead gain adjusterUS6853860Mar 5, 2003Feb 8, 2005Cardiac Pacemakers, Inc.Automatic shock lead gain adjusterUS6895274Aug 14, 2001May 17, 2005The Mower Family Chf Treatment Irrevocable TrustAntitachycardial pacingUS6912420Apr 10, 2001Jun 28, 2005Cardiac Pacemakers, Inc.Cardiac rhythm management system for hypotensionUS6968235Apr 30, 2002Nov 22, 2005Medtronic, Inc.Enhanced method and apparatus to identify and connect a small diameter lead with a low profile lead connectorUS6978171Mar 15, 2002Dec 20, 2005Medtronic, Inc.Automated impedance measurement of an implantable medical deviceUS6978178Apr 30, 2002Dec 20, 2005Medtronic, Inc.Method and apparatus for selecting an optimal electrode configuration of a medical electrical lead having a multiple electrode arrayUS7020513Jan 23, 2003Mar 28, 2006Ela Medical S.A.Testing the electrical continuity of the connecting cables for a recorder of physiological signals, in particular a holter recorder of ECG signalsUS7047083Sep 30, 2002May 16, 2006Medtronic, Inc.Method and apparatus for identifying lead-related conditions using lead impedance measurementsUS7050851 *Jun 29, 2001May 23, 2006Medtronic, Inc.Implantable cardioverter/defibrillator with housing electrode and lead detection and switching circuitryUS7076302Oct 10, 2002Jul 11, 2006Cardiac Pacemakers, Inc.Connection verification apparatus, systems, and methodsUS7113827 *Jan 16, 2004Sep 26, 2006Ela Medical S.A.S.Determining the presence and type of probe associated with an active implantable medical device, in particular a cardiac pacemakerUS7120493Jul 31, 2002Oct 10, 2006Cardiac Pacemakers, Inc.Shock lead impedance measurement to ensure safe delivery of shock therapy to maintain circuit integrityUS7149580 *Dec 13, 2004Dec 12, 2006Cardiac Pacemakers, Inc.Pacemaker passive measurement testing system and methodUS7177681Apr 11, 2003Feb 13, 2007Cardiac Pacemakers, Inc.Cardiac rhythm management system for edemaUS7191000Jul 31, 2001Mar 13, 2007Cardiac Pacemakers, Inc.Cardiac rhythm management system for edemaUS7200441Jun 21, 2004Apr 3, 2007Cardiac Pacemakers, Inc.Implantable cardiac stimulator with electrode-tissue interface characterizationUS7203537Jan 10, 2004Apr 10, 2007Mr3 Medical, LlcSystem and method for breaking reentry circuits by cooling cardiac tissueUS7226422Oct 9, 2002Jun 5, 2007Cardiac Pacemakers, Inc.Detection of congestion from monitoring patient response to a recumbent positionUS7233825Feb 15, 2003Jun 19, 2007Medtronic, Inc.Impedance measurement in implanted deviceUS7233826 *Apr 25, 2003Jun 19, 2007Medtronic, Inc.Bi-ventricular and single-ventricle pacingUS7239916Nov 14, 2003Jul 3, 2007Medtronic, Inc.Method and apparatus for automatic implantable medical lead recognition and configurationUS7299091Jul 1, 2003Nov 20, 2007Cyberonics, Inc.Treatment of obesity by bilateral vagus nerve stimulationUS7310557Apr 29, 2005Dec 18, 2007Maschino Steven EIdentification of electrodes for nerve stimulation in the treatment of eating disordersUS7340296May 18, 2005Mar 4, 2008Cardiac Pacemakers, Inc.Detection of pleural effusion using transthoracic impedanceUS7340306Aug 18, 2003Mar 4, 2008Cyberonics, Inc.Treatment of obesity by sub-diaphragmatic nerve stimulationUS7384395Jan 4, 2007Jun 10, 2008Cardiac Pacemakers, Inc.Detection of congestion from monitoring patient response to a recumbent positionUS7387610Aug 19, 2004Jun 17, 2008Cardiac Pacemakers, Inc.Thoracic impedance detection with blood resistivity compensationUS7422560Oct 29, 2007Sep 9, 2008Cardiac Pacemakers, Inc.Detection of congestion from monitoring patient response to a recumbent positionUS7440800May 31, 2005Oct 21, 2008Mr3 Medical, LlcSystem and method for managing detrimental cardiac remodelingUS7440801Jul 20, 2005Oct 21, 2008Ela Medical S.A.S.Implantable cardiac pacemaker with automatic control of the connection of a probe and the implantation of the caseUS7526341Mar 15, 2002Apr 28, 2009Medtronic, Inc.Amplitude ramping of waveforms generated by an implantable medical deviceUS7567840Oct 28, 2005Jul 28, 2009Cyberonics, Inc.Lead condition assessment for an implantable medical deviceUS7606619Jun 6, 2006Oct 20, 2009Cardiac Pacemakers, Inc.Connection verification apparatus, systems, and methodsUS7623919Apr 28, 2006Nov 24, 2009Medtronic, Inc.Distributed lead functionality testingUS7648499Mar 21, 2006Jan 19, 2010Covidien AgSystem and method for generating radio frequency energyUS7651492Apr 24, 2006Jan 26, 2010Covidien AgArc based adaptive control system for an electrosurgical unitUS7651493Mar 3, 2006Jan 26, 2010Covidien AgSystem and method for controlling electrosurgical snaresUS7658196Apr 25, 2007Feb 9, 2010Ethicon Endo-Surgery, Inc.System and method for determining implanted device orientationUS7672718Jun 16, 2008Mar 2, 2010Cardiac Pacemakers, Inc.Thoracic impedance detection with blood resistivity compensationUS7722601Apr 30, 2004May 25, 2010Covidien AgMethod and system for programming and controlling an electrosurgical generator systemUS7729765Nov 14, 2006Jun 1, 2010Cardiac Pacemakers, Inc.Pacemaker passive measurement testing system and methodUS7731717Aug 8, 2006Jun 8, 2010Covidien AgSystem and method for controlling RF output during tissue sealingUS7749217May 6, 2003Jul 6, 2010Covidien AgMethod and system for optically detecting blood and controlling a generator during electrosurgeryUS7751891Jul 28, 2004Jul 6, 2010Cyberonics, Inc.Power supply monitoring for an implantable deviceUS7766693Jun 16, 2008Aug 3, 2010Covidien AgConnector systems for electrosurgical generatorUS7766905Feb 4, 2005Aug 3, 2010Covidien AgMethod and system for continuity testing of medical electrodesUS7769455Jan 27, 2006Aug 3, 2010Cyberonics, Inc.Power supply monitoring for an implantable deviceUS7775215Mar 7, 2006Aug 17, 2010Ethicon Endo-Surgery, Inc.System and method for determining implanted device positioning and obtaining pressure dataUS7775966Mar 7, 2006Aug 17, 2010Ethicon Endo-Surgery, Inc.Non-invasive pressure measurement in a fluid adjustable restrictive deviceUS7780662Feb 23, 2005Aug 24, 2010Covidien AgVessel sealing system using capacitive RF dielectric heatingUS7794457Sep 28, 2006Sep 14, 2010Covidien AgTransformer for RF voltage sensingUS7797047Feb 18, 2004Sep 14, 2010Medtronic, Inc.Implantable lead functional status monitor and methodUS7824400Mar 3, 2006Nov 2, 2010Covidien AgCircuit for controlling arc energy from an electrosurgical generatorUS7834484Jul 16, 2007Nov 16, 2010Tyco Healthcare Group LpConnection cable and method for activating a voltage-controlled generatorUS7835796Apr 29, 2005Nov 16, 2010Cyberonics, Inc.Weight loss method and deviceUS7840264Mar 30, 2007Nov 23, 2010Mr3 Medical, LlcSystem and method for breaking reentry circuits by cooling cardiac tissueUS7844342Feb 7, 2008Nov 30, 2010Ethicon Endo-Surgery, Inc.Powering implantable restriction systems using lightUS7856273Jul 28, 2005Dec 21, 2010Cyberonics, Inc.Autonomic nerve stimulation to treat a gastrointestinal disorderUS7869884Apr 26, 2007Jan 11, 2011Cyberonics, Inc.Non-surgical device and methods for trans-esophageal vagus nerve stimulationUS7881781Dec 1, 2009Feb 1, 2011Cardiac Pacemakers, Inc.Thoracic impedance detection with blood resistivity compensationUS7899540Apr 29, 2005Mar 1, 2011Cyberonics, Inc.Noninvasively adjustable gastric bandUS7901400Jan 27, 2005Mar 8, 2011Covidien AgMethod and system for controlling output of RF medical generatorUS7904175Apr 26, 2007Mar 8, 2011Cyberonics, Inc.Trans-esophageal vagus nerve stimulationUS7907997May 11, 2005Mar 15, 2011Cardiac Pacemakers, Inc.Enhancements to the detection of pulmonary edema when using transthoracic impedanceUS7908003Jun 15, 2007Mar 15, 2011Mr3 Medical LlcSystem and method for treating ischemia by improving cardiac efficiencyUS7917204Oct 11, 2005Mar 29, 2011St. Jude Medical AbMethod and implantable medical device for measuring an electrical bio-impedance of a patientUS7927270Jan 29, 2007Apr 19, 2011Ethicon Endo-Surgery, Inc.External mechanical pressure sensor for gastric band pressure measurementsUS7927328Jan 24, 2007Apr 19, 2011Covidien AgSystem and method for closed loop monitoring of monopolar electrosurgical apparatusUS7930028Oct 20, 2006Apr 19, 2011Biotronik Crm Patent AgImplantable cardiac device with a shock leadUS7947039Dec 12, 2005May 24, 2011Covidien AgLaparoscopic apparatus for performing electrosurgical proceduresUS7953488Jul 31, 2008May 31, 2011Medtronic, Inc.Pre-qualification of an alternate sensing configurationUS7962214Jul 27, 2007Jun 14, 2011Cyberonics, Inc.Non-surgical device and methods for trans-esophageal vagus nerve stimulationUS7972328Jan 24, 2007Jul 5, 2011Covidien AgSystem and method for tissue sealingUS7972332Dec 16, 2009Jul 5, 2011Covidien AgSystem and method for controlling electrosurgical snaresUS7974690Jun 30, 2008Jul 5, 2011Medtronic, Inc.Lead integrity testing during suspected tachyarrhythmiasUS7974707Jan 26, 2007Jul 5, 2011Cyberonics, Inc.Electrode assembly with fibers for a medical deviceUS7979115Jan 10, 2008Jul 12, 2011Cardiac Pacemakers, Inc.Detection of pleural effusion using transthoracic impedanceUS8010207Apr 21, 2003Aug 30, 2011Medtronic, Inc.Implantable medical lead designsUS8012150Apr 30, 2004Sep 6, 2011Covidien AgMethod and system for programming and controlling an electrosurgical generator systemUS8016744Mar 7, 2006Sep 13, 2011Ethicon Endo-Surgery, Inc.External pressure-based gastric band adjustment system and methodUS8016745Apr 6, 2006Sep 13, 2011Ethicon Endo-Surgery, Inc.Monitoring of a food intake restriction deviceUS8024040Jun 7, 2004Sep 20, 2011Cardiac Pacemakers, Inc.Method and system for treatment of neurocardiogenic syncopeUS8025660Nov 18, 2009Sep 27, 2011Covidien AgUniversal foot switch contact portUS8034049Aug 8, 2006Oct 11, 2011Covidien AgSystem and method for measuring initial tissue impedanceUS8034065Feb 26, 2008Oct 11, 2011Ethicon Endo-Surgery, Inc.Controlling pressure in adjustable restriction devicesUS8036737Oct 19, 2005Oct 11, 2011Medtronic, Inc.Automated impedance measurement of an implantable medical deviceUS8046071Apr 22, 2010Oct 25, 2011Cardiac Pacemakers, Inc.Pacemaker passive measurement testing systemUS8057492Feb 12, 2008Nov 15, 2011Ethicon Endo-Surgery, Inc.Automatically adjusting band system with MEMS pumpUS8066629Feb 12, 2007Nov 29, 2011Ethicon Endo-Surgery, Inc.Apparatus for adjustment and sensing of gastric band pressureUS8078277Oct 29, 2008Dec 13, 2011Medtronic, Inc.Identification and remediation of oversensed cardiac events using far-field electrogramsUS8080008Sep 18, 2007Dec 20, 2011Covidien AgMethod and system for programming and controlling an electrosurgical generator systemUS8096961Jun 27, 2008Jan 17, 2012Covidien AgSwitched resonant ultrasonic power amplifier systemUS8100870Dec 14, 2007Jan 24, 2012Ethicon Endo-Surgery, Inc.Adjustable height gastric restriction devices and methodsUS8104956Oct 23, 2003Jan 31, 2012Covidien AgThermocouple measurement circuitUS8105323Oct 24, 2006Jan 31, 2012Covidien AgMethod and system for controlling output of RF medical generatorUS8113057Jun 27, 2008Feb 14, 2012Covidien AgSwitched resonant ultrasonic power amplifier systemUS8114345Feb 8, 2008Feb 14, 2012Ethicon Endo-Surgery, Inc.System and method of sterilizing an implantable medical deviceUS8126553Jul 25, 2008Feb 28, 2012Medtronic, Inc.Sensing integrity determination based on cardiovascular pressureUS8142452Dec 27, 2007Mar 27, 2012Ethicon Endo-Surgery, Inc.Controlling pressure in adjustable restriction devicesUS8147485Feb 23, 2009Apr 3, 2012Covidien AgSystem and method for tissue sealingUS8152710Feb 28, 2008Apr 10, 2012Ethicon Endo-Surgery, Inc.Physiological parameter analysis for an implantable restriction device and a data loggerUS8180462Apr 18, 2006May 15, 2012Cyberonics, Inc.Heat dissipation for a lead assemblyUS8185203Dec 11, 2008May 22, 2012Cardiac Pacemakers, Inc.Vector configuration detection and corrective response systems and methodsUS8187162Mar 6, 2008May 29, 2012Ethicon Endo-Surgery, Inc.Reorientation portUS8187163Dec 10, 2007May 29, 2012Ethicon Endo-Surgery, Inc.Methods for implanting a gastric restriction deviceUS8187262Jun 3, 2009May 29, 2012Covidien AgDual synchro-resonant electrosurgical apparatus with bi-directional magnetic couplingUS8190258Jul 7, 2009May 29, 2012Cyberonics, Inc.Lead condition assessment for an implantable medical deviceUS8192350Jan 28, 2008Jun 5, 2012Ethicon Endo-Surgery, Inc.Methods and devices for measuring impedance in a gastric restriction systemUS8200322Jul 30, 2008Jun 12, 2012Medtronic, Inc.Electrogram storage for suspected non-physiological episodesUS8200326Sep 10, 2009Jun 12, 2012Cardiac Pacemakers, Inc.Calibration of impedance monitoring of respiratory volumes using thoracic D.C. impedanceUS8202271Feb 25, 2009Jun 19, 2012Covidien AgDual synchro-resonant electrosurgical apparatus with bi-directional magnetic couplingUS8216220Sep 7, 2007Jul 10, 2012Tyco Healthcare Group LpSystem and method for transmission of combined data streamUS8216223Feb 23, 2009Jul 10, 2012Covidien AgSystem and method for tissue sealingUS8221439Feb 7, 2008Jul 17, 2012Ethicon Endo-Surgery, Inc.Powering implantable restriction systems using kinetic motionUS8226639Jun 10, 2008Jul 24, 2012Tyco Healthcare Group LpSystem and method for output control of electrosurgical generatorUS8231616Aug 23, 2010Jul 31, 2012Covidien AgTransformer for RF voltage sensingUS8233995Mar 6, 2008Jul 31, 2012Ethicon Endo-Surgery, Inc.System and method of aligning an implantable antennaUS8241278Apr 29, 2011Aug 14, 2012Covidien AgLaparoscopic apparatus for performing electrosurgical proceduresUS8255055Feb 6, 2009Aug 28, 2012Cardiac Pacemakers, Inc.MRI shielding in electrodes using AC pacingUS8267928Mar 29, 2011Sep 18, 2012Covidien AgSystem and method for closed loop monitoring of monopolar electrosurgical apparatusUS8267929Dec 16, 2011Sep 18, 2012Covidien AgMethod and system for programming and controlling an electrosurgical generator systemUS8287528Mar 28, 2008Oct 16, 2012Covidien AgVessel sealing systemUS8290585Jan 21, 2002Oct 16, 2012Mr3 Medical, LlcAugmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood poolUS8295943Aug 20, 2008Oct 23, 2012Medtronic, Inc.Implantable medical lead with biased electrodeUS8295946May 23, 2011Oct 23, 2012Cyberonics, Inc.Electrode assembly with fibers for a medical deviceUS8298223Apr 5, 2010Oct 30, 2012Covidien AgMethod and system for programming and controlling an electrosurgical generator systemUS8303580Apr 5, 2010Nov 6, 2012Covidien AgMethod and system for programming and controlling an electrosurgical generator systemUS8306630Oct 15, 2010Nov 6, 2012Cardiac Pacemakers, Inc.Apparatus to selectively increase medical device lead inner conductor inductanceUS8326418Aug 20, 2008Dec 4, 2012Medtronic, Inc.Evaluating therapeutic stimulation electrode configurations based on physiological responsesUS8337389Jan 28, 2008Dec 25, 2012Ethicon Endo-Surgery, Inc.Methods and devices for diagnosing performance of a gastric restriction systemUS8353905Jun 18, 2012Jan 15, 2013Covidien LpSystem and method for transmission of combined data streamUS8355783Oct 9, 2009Jan 15, 2013Medtronic, Inc.Distributed lead functionality testingUS8355784May 13, 2011Jan 15, 2013Medtronic, Inc.Dynamic representation of multipolar leads in a programmer interfaceUS8369964Sep 13, 2010Feb 5, 2013Cardiac Pacemakers, Inc.MRI compatible medical device lead including transmission line notch filtersUS8377079Dec 27, 2007Feb 19, 2013Ethicon Endo-Surgery, Inc.Constant force mechanisms for regulating restriction devicesUS8396543Jan 28, 2010Mar 12, 2013Medtronic, Inc.Storage of data for evaluation of lead integrityUS8406895Oct 19, 2010Mar 26, 2013Cardiac Pacemakers, Inc.Implantable electrical lead including a cooling assembly to dissipate MRI induced electrode heatUS8433422Apr 20, 2007Apr 30, 2013Medtronic, Inc.Implantable medical electrical lead and connector assemblyUS8437840Sep 26, 2011May 7, 2013Medtronic, Inc.Episode classifier algorithmUS8447399Apr 1, 2008May 21, 2013Mr3 Medical, LlcSystem and method for managing detrimental cardiac remodelingUS8463382 *Aug 26, 2010Jun 11, 2013Medtronic, Inc.Implantable lead functional status monitor and methodUS8463384Jan 27, 2011Jun 11, 2013Medtronic, Inc.Isolated lead conductor measurements for fault detectionUS8475447Aug 23, 2012Jul 2, 2013Covidien AgSystem and method for closed loop monitoring of monopolar electrosurgical apparatusUS8478420Jul 12, 2006Jul 2, 2013Cyberonics, Inc.Implantable medical device charge balance assessmentUS8478428Apr 23, 2010Jul 2, 2013Cyberonics, Inc.Helical electrode for nerve stimulationUS8483818Feb 23, 2011Jul 9, 2013Cardiac Pacemakers, Inc.Enhancements to the detection of pulmonary edema when using transthoracic impedanceUS8483829Sep 20, 2012Jul 9, 2013Medtronic, Inc.Dynamic representation of multipolar leads in a programmer interfaceUS8483846Apr 8, 2010Jul 9, 2013Cyberonics, Inc.Multi-electrode assembly for an implantable medical deviceUS8485993Jan 16, 2012Jul 16, 2013Covidien AgSwitched resonant ultrasonic power amplifier systemUS8486061Aug 24, 2012Jul 16, 2013Covidien LpImaginary impedance process monitoring and intelligent shut-offUS8494634May 21, 2012Jul 23, 2013Cardiac Pacemakers, Inc.Vector configuration detection and corrective response systems and methodsUS8512332Sep 21, 2007Aug 20, 2013Covidien LpReal-time arc control in electrosurgical generatorsUS8521281Oct 14, 2011Aug 27, 2013Medtronic, Inc.Electrogram classification algorithmUS8523855Aug 23, 2010Sep 3, 2013Covidien AgCircuit for controlling arc energy from an electrosurgical generatorUS8532773May 1, 2012Sep 10, 2013Cyberonics, Inc.Lead condition assessment for an implantable medical deviceUS8538523Sep 14, 2012Sep 17, 2013Medtronic, Inc.Evaluating therapeutic stimulation electrode configurations based on physiological responsesUS8556890Dec 14, 2009Oct 15, 2013Covidien AgArc based adaptive control system for an electrosurgical unitUS8560070Mar 17, 2010Oct 15, 2013Cyberonics, Inc.Power supply monitoring for an implantable deviceUS8565881Jun 22, 2010Oct 22, 2013Cyberonics, Inc.Power supply monitoring for an implantable deviceUS8577457Jul 7, 2011Nov 5, 2013Medtronics, Inc.Isolating lead body for fault detectionUS8577459Jan 28, 2011Nov 5, 2013Cyberonics, Inc.System and method for estimating battery capacityUS8591395Jan 28, 2008Nov 26, 2013Ethicon Endo-Surgery, Inc.Gastric restriction device data handling devices and methodsUS8591532Feb 12, 2008Nov 26, 2013Ethicon Endo-Sugery, Inc.Automatically adjusting band systemUS8630719Oct 22, 2012Jan 14, 2014Medtronic, Inc.Implantable medical lead with biased electrodeUS8639337Oct 13, 2011Jan 28, 2014Cardiac Pacemakers, Inc.Pacemaker passive measurement testing systemUS8644931Jul 25, 2008Feb 4, 2014Medtronic, Inc.Impedance variability analysis to identify lead-related conditionsUS8647340Jan 4, 2012Feb 11, 2014Covidien AgThermocouple measurement systemUS8663214Jan 24, 2007Mar 4, 2014Covidien AgMethod and system for controlling an output of a radio-frequency medical generator having an impedance based control algorithmUS8685016Feb 23, 2009Apr 1, 2014Covidien AgSystem and method for tissue sealingUS8734438Oct 21, 2005May 27, 2014Covidien AgCircuit and method for reducing stored energy in an electrosurgical generatorUS8744560Sep 30, 2011Jun 3, 2014Medtronic, Inc.Electrogram summaryUS8751000Oct 2, 2013Jun 10, 2014Medtronic, Inc.Isolating lead body for fault detectionUS8753276Mar 8, 2012Jun 17, 2014Cardiac Pacemakers, Inc.Physiological response to posture changeUS8753334May 10, 2006Jun 17, 2014Covidien AgSystem and method for reducing leakage current in an electrosurgical generatorUS8761884Apr 14, 2011Jun 24, 2014Cyberonics, Inc.Device longevity prediction for a device having variable energy consumptionUS8761885Apr 29, 2011Jun 24, 2014Cyberonics, Inc.Battery life estimation based on voltage depletion rateUS8774909Sep 26, 2011Jul 8, 2014Medtronic, Inc.Episode classifier algorithmUS8777941May 10, 2007Jul 15, 2014Covidien LpAdjustable impedance electrosurgical electrodesUS8781585Nov 21, 2011Jul 15, 2014Medtronic, Inc.Identification and remediation of oversensed cardiac events using far-field electrogramsUS8798751Jun 9, 2011Aug 5, 2014Medtronic, Inc.Method and apparatus to manage lead-related conditions for fault tolerance enhancementsUS8798767Nov 5, 2010Aug 5, 2014Cardiac Pacemakers, Inc.MRI conditionally safe lead with multi-layer conductorUS8808161Oct 23, 2003Aug 19, 2014Covidien AgRedundant temperature monitoring in electrosurgical systems for safety mitigationUS8825179Apr 19, 2013Sep 2, 2014Cardiac Pacemakers, Inc.Implantable medical device lead including a unifilar coiled cableUS8825181Jun 9, 2011Sep 2, 2014Cardiac Pacemakers, Inc.Lead conductor with pitch and torque control for MRI conditionally safe useUS8855765Jun 9, 2011Oct 7, 2014Medtronic, Inc.Fault tolerant methods and architectures for embedded intelligence in medical leadsUS8868203Oct 26, 2007Oct 21, 2014Cyberonics, Inc.Dynamic lead condition detection for an implantable medical deviceUS8870742Feb 28, 2008Oct 28, 2014Ethicon Endo-Surgery, Inc.GUI for an implantable restriction device and a data loggerUS8874229Apr 28, 2010Oct 28, 2014Cyberonics, Inc.Delivering scheduled and unscheduled therapy without detriment to battery life or accuracy of longevity predictionsUS8886296Oct 14, 2011Nov 11, 2014Medtronic, Inc.T-wave oversensingUS8942798Oct 26, 2007Jan 27, 2015Cyberonics, Inc.Alternative operation mode for an implantable medical device based upon lead conditionUS8954168Mar 13, 2013Feb 10, 2015Cardiac Pacemakers, Inc.Implantable device lead including a distal electrode assembly with a coiled componentUS8958889Aug 30, 2013Feb 17, 2015Cardiac Pacemakers, Inc.MRI compatible lead coilUS8966981Jul 16, 2013Mar 3, 2015Covidien AgSwitched resonant ultrasonic power amplifier systemUS8983623Oct 17, 2013Mar 17, 2015Cardiac Pacemakers, Inc.Inductive element for providing MRI compatibility in an implantable medical device leadUS8996111Apr 27, 2012Mar 31, 2015Medtronic, Inc.Lead recognition for an implantable medical systemUS9037240Jul 25, 2008May 19, 2015Medtronic, Inc.Electrode lead integrity reportsUS9050457Feb 6, 2014Jun 9, 2015Cardiac Pacemakers, Inc.MRI conditionally safe lead with low-profile conductor for longitudinal expansionUS9079037Apr 27, 2012Jul 14, 2015Medtronic, Inc.Fault tolerant implantable medical systemUS9084883Feb 12, 2010Jul 21, 2015Cardiac Pacemakers, Inc.Thin profile conductor assembly for medical device leadsUS9089275May 11, 2005Jul 28, 2015Cardiac Pacemakers, Inc.Sensitivity and specificity of pulmonary edema detection when using transthoracic impedanceUS9113900Jan 31, 2012Aug 25, 2015Covidien AgMethod and system for controlling output of RF medical generatorUS9119624Oct 8, 2013Sep 1, 2015Covidien AgARC based adaptive control system for an electrosurgical unitUS9126054May 13, 2014Sep 8, 2015Cyberonics, Inc.Device longevity prediction for a device having variable energy consumptionUS9138585Aug 4, 2011Sep 22, 2015Cardiac Pacemakers, Inc.User interface system for use with multipolar pacing leadsUS9168089Jan 31, 2012Oct 27, 2015Covidien AgMethod and system for controlling output of RF medical generatorUS9186200May 30, 2012Nov 17, 2015Covidien AgSystem and method for tissue sealingUS9186499Apr 27, 2010Nov 17, 2015Medtronic, Inc.Grounding of a shield within an implantable medical leadUS9199077Jul 10, 2014Dec 1, 2015Cardiac Pacemakers, Inc.MRI conditionally safe lead with multi-layer conductorUS9205253Apr 27, 2010Dec 8, 2015Medtronic, Inc.Shielding an implantable medical leadUS9216286Apr 28, 2010Dec 22, 2015Medtronic, Inc.Shielded implantable medical lead with guarded terminationUS9220893Dec 1, 2014Dec 29, 2015Medtronic, Inc.Shielded implantable medical lead with reduced torsional stiffnessUS9220913May 6, 2014Dec 29, 2015Medtronics, Inc.Multi-mode implantable medical deviceUS9232898Oct 18, 2012Jan 12, 2016Medtronic, Inc.Method and apparatus to manage lead-related conditions for fault tolerance enhancementsUS9242110Aug 3, 2015Jan 26, 2016Cyberonics, Inc.Device longevity prediction for a device having variable energy consumptionUS9254380Sep 13, 2010Feb 9, 2016Cardiac Pacemakers, Inc.MRI compatible tachycardia leadUS9259572Jun 2, 2014Feb 16, 2016Medtronic, Inc.Lead or lead extension having a conductive body and conductive body contactUS9265950May 12, 2008Feb 23, 2016Cardiac Pacemakers, Inc.Contractility modulation based on impedance signalUS9271790Aug 20, 2013Mar 1, 2016Coviden LpReal-time arc control in electrosurgical generatorsUS9272136Aug 11, 2014Mar 1, 2016Medtronic, Inc.Grounding of a shield within an implantable medical leadUS9302100Feb 13, 2014Apr 5, 2016Medtronic, Inc.Lead monitoring frequency based on lead and patient characteristicsUS9302101Mar 17, 2014Apr 5, 2016Medtronic, Inc.MRI-safe implantable leadUS9333344Dec 22, 2014May 10, 2016Cardiac Pacemakers, Inc.Implantable device lead including a distal electrode assembly with a coiled componentUS9399141Feb 13, 2014Jul 26, 2016Medtronic, Inc.Lead monitoring frequency based on lead and patient characteristicsUS9409026Feb 13, 2014Aug 9, 2016Medtronic, Inc.Lead monitoring frequency based on lead and patient characteristicsUS9421355Oct 15, 2014Aug 23, 2016Cyberonics, Inc.Delivering scheduled and unscheduled therapy without detriment to battery life or accuracy of longevity predictionsUS9452284Jul 21, 2014Sep 27, 2016Medtronic, Inc.Termination of a shield within an implantable medical leadUS9463317Jan 29, 2013Oct 11, 2016Medtronic, Inc.Paired medical lead bodies with braided conductive shields having different physical parameter valuesUS9474564Mar 27, 2006Oct 25, 2016Covidien AgMethod and system for compensating for external impedance of an energy carrying component when controlling an electrosurgical generatorUS9504821Feb 25, 2015Nov 29, 2016Cardiac Pacemakers, Inc.Construction of an MRI-safe tachycardia leadUS9504822Mar 15, 2015Nov 29, 2016Cardiac Pacemakers, Inc.Inductive element for providing MRI compatibility in an implantable medical device leadUS9522032May 21, 2014Dec 20, 2016Covidien AgCircuit and method for reducing stored energy in an electrosurgical generatorUS9522277Jul 28, 2008Dec 20, 2016Medtronic, Inc.Lead integrity testing triggered by sensed signal saturationUS9539428Jan 27, 2011Jan 10, 2017Medtronic, Inc.Isolating lead conductor for fault detectionUS20020095188 *Aug 14, 2001Jul 18, 2002Mower Morton M.Antitachycardial pacingUS20030004552 *Jun 29, 2001Jan 2, 2003Medtronic, Inc.Implantable cardioverter/defibrillatorUS20030018364 *Apr 30, 2002Jan 23, 2003Medtronic, Inc.Enhanced method and apparatus to identify and connect a small diameter lead with a low profile lead connectorUS20030163170 *Jan 23, 2003Aug 28, 2003Yves FaisandierTesting the electrical continuity of the connecting cables for a recorder of physiological signals, in particular a holter recorder of ECG signalsUS20030176807 *Mar 15, 2002Sep 18, 2003Medtronic, Inc.Automated impedance measurement of an implantable medical deviceUS20030191503 *Apr 11, 2003Oct 9, 2003Cardiac Pacemakers, Inc.Cardiac rhythm management system for edemaUS20030199938 *Apr 22, 2002Oct 23, 2003Karel SmitsPrecise cardiac lead placement based on impedance measurementsUS20030204232 *Apr 30, 2002Oct 30, 2003Sommer John L.Method and apparatus for selecting an optimal electrode configuration of a medical electrical lead having a multiple electrode arrayUS20040024424 *Jul 31, 2002Feb 5, 2004Propp Hal M.Shock lead impedance measurement to ensure safe delivery of shock therapy to maintain circuit integrityUS20040064161 *Sep 30, 2002Apr 1, 2004Gunderson Bruce D.Method and apparatus for identifying lead-related conditions using lead impedance measurementsUS20040073266 *Oct 15, 2002Apr 15, 2004Haefner Paul A.Automatic detection of defibrillation leadUS20040078067 *Nov 14, 2003Apr 22, 2004Medtronic, Inc.Method and apparatus for automatic implantable medical lead recognition and configurationUS20040088033 *Apr 21, 2003May 6, 2004Smits Karel F.A.A.Implantable medical lead designsUS20040147970 *Jan 20, 2004Jul 29, 2004Cardiac Pacemakers, Inc.Automatic shock lead gain adjusterUS20040162591 *Feb 15, 2003Aug 19, 2004Medtronic, Inc.Impedance measurement in implanted deviceUS20040162593 *Feb 18, 2004Aug 19, 2004Medtronic, Inc.Implantable lead functional status monitor and methodUS20040176822 *Nov 14, 2003Sep 9, 2004Medtronic, Inc.Method and apparatus for automatic implantable medical lead recognition and configurationUS20040215256 *Apr 25, 2003Oct 28, 2004Keizer Diederick M.Bi-ventricular and single-ventricle pacingUS20040220625 *Jan 16, 2004Nov 4, 2004Luigi SilvestriDetermining the presence and type of probe associated with an active implantable medical device, in particular a cardiac pacemakerUS20040230245 *Jun 21, 2004Nov 18, 2004Intermedics Inc.Implantable cardiac stimulator with electrode-tissue interface characterizationUS20050004628 *Mar 15, 2002Jan 6, 2005Medtronic, IncAmplitude ramping of waveforms generated by an implantable medical deviceUS20050021098 *Jun 7, 2004Jan 27, 2005Cardiac Pacemakers, Inc.Method and system for treatment of neurocardiogenic syncopeUS20050096701 *Aug 13, 2004May 5, 2005Medtronic, Inc.Stimulation for delivery of molecular therapyUS20050102004 *Dec 13, 2004May 12, 2005Cardiac Pacemakers, Inc.Pacemaker passive measurement testing system and methodUS20050277993 *May 31, 2005Dec 15, 2005Mower Morton MSystem and method for managing detrimental cardiac remodelingUS20060025828 *Jul 28, 2004Feb 2, 2006Armstrong Randolph KImpedance measurement for an implantable deviceUS20060025829 *Jul 28, 2004Feb 2, 2006Armstrong Randolph KPower supply monitoring for an implantable deviceUS20060036186 *Oct 19, 2005Feb 16, 2006Medtronic, Inc.Automated impedance measurement of an implantable medical deviceUS20060041280 *Aug 19, 2004Feb 23, 2006Cardiac Pacemakers, Inc.Thoracic impedance detection with blood resistivity compensationUS20060052833 *Jul 20, 2005Mar 9, 2006Ela Medical S.A.Implantable cardiac pacemaker with automatic control of the connection of a probe and the implantation of the caseUS20060247719 *Apr 29, 2005Nov 2, 2006Cyberonics, Inc.Weight loss method and adviceUS20060247721 *Apr 29, 2005Nov 2, 2006Cyberonics, Inc.Identification of electrodes for nerve stimulation in the treatment of eating disordersUS20060247722 *Apr 29, 2005Nov 2, 2006Cyberonics, Inc.Noninvasively adjustable gastric bandUS20060258952 *May 11, 2005Nov 16, 2006Cardiac Pacemakers, Inc.Enhancements to the detection of pulmonary edema when using transthoracic impedanceUS20060265017 *May 31, 2005Nov 23, 2006Mower Morton MSystem and method for managing detrimental cardiac remodelingUS20060265024 *Apr 28, 2006Nov 23, 2006Medtronic, Inc.Distributed lead functionality testingUS20060265025 *Apr 28, 2006Nov 23, 2006Medtronic, Inc.Automatic lead functionality testingUS20060293609 *May 11, 2005Dec 28, 2006Cardiac Pacemakers, Inc.Sensitivity and specificity of pulmonary edema detection when using transthoracic impedanceUS20070073349 *Nov 14, 2006Mar 29, 2007Cardiac Pacemakers, Inc.Pacemaker passive measurement testing system and methodUS20070100407 *Oct 28, 2005May 3, 2007Cyberonics, Inc.Lead condition assessment for an implantable medical deviceUS20070106130 *Jan 4, 2007May 10, 2007Cardiac Pacemakers, Inc.Detection of congestion from monitoring patient response to a recumbent positionUS20070164183 *Dec 20, 2006Jul 19, 2007Thomas & Betts International, Inc.Rework bracket for electrical outlet boxesUS20070179547 *Jan 27, 2006Aug 2, 2007Cyberonics, Inc.Power supply monitoring for an implantable deviceUS20080097531 *Oct 20, 2006Apr 24, 2008Volker LangImplantable cardiac device with a shock leadUS20080215108 *May 12, 2008Sep 4, 2008Cardiac Pacemakers, Inc.Cardiac rhythm management system for edemaUS20080221477 *Oct 11, 2005Sep 11, 2008Allan OlsonMethod and Implantable Medical Device for Measuring an Electrical Bio-Impedance of a PatientUS20080262582 *Apr 20, 2007Oct 23, 2008Medtronic, Inc.Implantable medical electrical lead and connector assemblyUS20080269833 *Apr 26, 2007Oct 30, 2008Cyberonics, Inc.Trans-esophageal vagus nerve stimulationUS20080269834 *Jul 27, 2007Oct 30, 2008Cyberonics Inc.Non-Surgical Device and Methods for Trans-Esophageal Vagus Nerve StimulationUS20080269840 *Apr 26, 2007Oct 30, 2008Cyberonics, Inc.Non-surgical device and methods for trans-esophageal vagus nerve stimulationUS20080287855 *Apr 1, 2008Nov 20, 2008Mower Morton MSystem and method for managing detrimental cardiac remodelingUS20090054947 *Aug 20, 2008Feb 26, 2009Medtronic, Inc.Electrode configurations for directional leadsUS20090112292 *Oct 26, 2007Apr 30, 2009Cyberonics Inc.Dynamic lead condition detection for an implantable medical deviceUS20090125079 *Oct 26, 2007May 14, 2009Cyberonics Inc.Alternative operation mode for an implantable medical device based upon lead conditionUS20090157137 *Dec 11, 2008Jun 18, 2009Cardiac Pacemakers, Inc.Vector Configuration Detection and Corrective Response Systems and MethodsUS20090204171 *Feb 6, 2009Aug 13, 2009Masoud AmeriMri shielding in electrodes using ac pacingUS20090270959 *Jul 7, 2009Oct 29, 2009Cyberonics Inc.Lead condition assessment for an implantable medical deviceUS20090299201 *Jul 25, 2008Dec 3, 2009Medtronic, Inc.Electrode lead integrity reportsUS20090299421 *Jul 24, 2008Dec 3, 2009Medtronic, Inc.Evaluation of implantable medical device sensing integrity based on evoked signalsUS20090299422 *Jul 30, 2008Dec 3, 2009Medtronic, Inc.Electrogram storage for suspected non-physiological episodesUS20090299429 *Jul 25, 2008Dec 3, 2009Medtronic, Inc.Sensing integrity determination based on cardiovascular pressureUS20090299432 *Jul 25, 2008Dec 3, 2009Metronic, Inc.Impedance variability analysis to identify lead-related conditionsUS20090326600 *Jun 30, 2008Dec 31, 2009Medtronic, Inc.Lead integrity testing during suspected tachyarrhythmiasUS20100030286 *Oct 9, 2009Feb 4, 2010Medtronic, Inc.Distributed lead functionality testingUS20100030289 *Jul 31, 2008Feb 4, 2010Medtronic, Inc.Pre-qualification of an alternate sensing configurationUS20100106209 *Oct 29, 2008Apr 29, 2010Medtronic, Inc.Identification and remediation of oversensed cardiac events using far-field electrogramsUS20100106215 *Sep 14, 2009Apr 29, 2010Stubbs Scott RSystems and methods to detect implantable medical device configuaration changes affecting mri conditional safetyUS20100198313 *Mar 17, 2010Aug 5, 2010Cyberonics, Inc.Power supply monitoring for an implantable deviceUS20100204746 *Apr 22, 2010Aug 12, 2010Conley Vickie LPacemaker passive measurement testing system and methodUS20100268495 *Jun 22, 2010Oct 21, 2010Cyberonics, Inc.Power supply monitoring for an implantable deviceUS20100324629 *Aug 26, 2010Dec 23, 2010Medtronic, Inc.Implantable lead functional status monitor and methodUS20110087302 *Sep 13, 2010Apr 14, 2011Masoud AmeriMri compatible medical device lead including transmission line notch filtersUS20110093054 *Sep 13, 2010Apr 21, 2011Masoud AmeriMri compatible tachycardia leadUS20110160805 *Oct 19, 2010Jun 30, 2011Blair ErbstoeszerImplantable electrical lead including a cooling assembly to dissipate mri induced electrode heatUS20110160816 *Oct 15, 2010Jun 30, 2011Stubbs Scott RApparatus to selectively increase medical device lead inner conductor inductanceUS20110160829 *Nov 5, 2010Jun 30, 2011Foster Arthur JMri conditionally safe lead with multi-layer conductorUS20110184481 *Jan 28, 2010Jul 28, 2011Medtronic, Inc.Storage of data for evaluation of lead integrityEP1330980A1 *Jan 22, 2003Jul 30, 2003Ela MedicalApparatus for recording physiological signals, in particular of the Holter type, with cable continuity testingEP1618923A1 *Jul 21, 2005Jan 25, 2006Ela MedicalImplantierbarer Herzschrittmacher mit automatischer Detektion des Installieren einer Sonde und der Implantation des GehäusesWO1998019738A1 *Oct 8, 1997May 14, 1998Medtronic, Inc.Cardioversion/defibrillation lead impedance measurement systemWO1998033553A1Jan 8, 1998Aug 6, 1998Medtronic, Inc.Impedance respiratory rate measuring edema monitorWO1998033554A1Jan 29, 1998Aug 6, 1998Medtronic, Inc.Implantable impedance measurement systemWO1999024112A1Nov 4, 1998May 20, 1999Medtronic, Inc.Non-physiologic sense detection for implantable medical devicesWO1999024113A1Nov 4, 1998May 20, 1999Medtronic, Inc.Pacing lead impedance monitoring circuit and methodWO1999058192A1May 6, 1999Nov 18, 1999Intermedics Inc.Implantable cardiac stimulator with electrode-tissue interface characterizationWO2001014003A1 *Aug 14, 2000Mar 1, 2001Cardiac Pacemakers, Inc.Automatic shock lead gain adjusterWO2003077992A1 *Mar 7, 2003Sep 25, 2003Medtronic, Inc.Automated impedance measurement of an implantable medical deviceWO2004033032A2 *Oct 10, 2003Apr 22, 2004Cardiac Pacemakers, Inc.Connection verification apparatus, system, and methodWO2004033032A3 *Oct 10, 2003Jun 17, 2004Cardiac Pacemakers IncConnection verification apparatus, system, and methodWO2004035134A2 *Oct 15, 2003Apr 29, 2004Cardiac Pacemakers, Inc.Automatic detection of defibrillation leadWO2004035134A3 *Oct 15, 2003Sep 10, 2004Cardiac Pacemakers IncAutomatic detection of defibrillation leadWO2007043923A1 *Oct 11, 2005Apr 19, 2007St. Jude Medical AbMethod and implantable medical device for measuring an electrical bio-impedance of a patientWO2009042749A3 *Sep 25, 2008Sep 17, 2009Medtronic, IncDetecting overloading of an analog-to-digital converter of an implantable medical deviceWO2012170325A2Jun 4, 2012Dec 13, 2012Medtronic, Inc.Method and apparatus to manage lead-related conditions for fault tolerance enhancementsWO2013162713A1Mar 7, 2013Oct 31, 2013Medtronic, Inc.Fault tolerant implantable medical systemWO2015112657A1Jan 22, 2015Jul 30, 2015Medtronic, Inc.Pre-implant detectionWO2015123483A1Feb 13, 2015Aug 20, 2015Medtronic, Inc.Lead monitoring frequency based on lead and patient characteristics* Cited by examinerClassifications U.S. Classification607/27, 607/29, 607/9, 607/28International ClassificationA61N1/37, A61N1/08Cooperative ClassificationA61N2001/083, A61N1/3706European ClassificationA61N1/37CLegal EventsDateCodeEventDescriptionFeb 6, 1995ASAssignmentOwner name: MEDTRONIC, INC., MINNESOTAFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WAHLSTRAND, JOHN D.;BAXTER, DANIEL J.;ECKER, R. MICHAEL;AND OTHERS;REEL/FRAME:007332/0324Effective date: 19950106Jan 3, 2000FPAYFee paymentYear of fee payment: 4Dec 23, 2003FPAYFee paymentYear of fee payment: 8Jan 4, 2008FPAYFee paymentYear of fee payment: 12RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services